Nutritional counseling improves mortality and prevents hepatic encephalopathy in patients with alcohol-associated liver disease
- PMID: 38683882
- DOI: 10.1111/hepr.14053
Nutritional counseling improves mortality and prevents hepatic encephalopathy in patients with alcohol-associated liver disease
Abstract
Aim: Nutritional counseling improves malnutrition, which determines the prognosis of patients with chronic liver disease. In this study, we investigated the effects of nutritional counseling on mortality and the risk of overt hepatic encephalopathy (HE) in patients with alcohol-associated liver disease.
Methods: In this retrospective cohort study, we included 211 patients with alcohol-associated liver disease who visited Gifu University Hospital between August 2008 and June 2023. Patients were classified into two groups according to the frequency of nutritional counseling by a registered dietitian. The primary outcomes were all-cause mortality and overt HE. Propensity score matching analysis was performed to adjust for potential confounders.
Results: Among the patients (median age 67 years; 88% men; and median Model for End-Stage Liver Disease score, 9), 86 (39%) were in the high-frequency (≥2) nutritional counseling group. The high-frequency group had a significantly higher survival rate (46% vs. 25%) and a lower incidence of overt HE (16% vs. 27%) at 5 years than the low-frequency group. Nutritional counseling was associated with a reduced risk of mortality (hazard ratio [HR] 0.48; 95% confidence interval [CI] 0.36-0.63) and overt HE (HR 0.64; 95% CI 0.42-0.99), independent of hepatocellular carcinoma and liver function reserve. After propensity score matching, nutritional counseling was still associated with a reduced risk of mortality (HR 0.34; 95% CI 0.19-0.59) and overt HE (HR 0.31; 95% CI 0.11-0.87).
Conclusions: Nutritional counseling effectively improves mortality and prevents overt HE in patients with alcohol-associated liver disease, thereby proving essential for the management of these patients.
Keywords: alcohol‐associated liver disease; dietary intervention; malnutrition; nutritional counseling; sarcopenia.
© 2024 Japan Society of Hepatology.
Similar articles
-
Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis.J Gastroenterol Hepatol. 2019 Oct;34(10):1809-1816. doi: 10.1111/jgh.14635. Epub 2019 Mar 14. J Gastroenterol Hepatol. 2019. PMID: 30779213
-
Customized nutrition intervention and personalized counseling helps achieve nutrition targets in perioperative liver transplant patients.Clin Nutr ESPEN. 2018 Feb;23:200-204. doi: 10.1016/j.clnesp.2017.09.014. Epub 2017 Oct 26. Clin Nutr ESPEN. 2018. PMID: 29460799
-
Bacterial DNA Translocation Is Associated With Overt Hepatic Encephalopathy and Mortality in Patients With Cirrhosis.Clin Transl Gastroenterol. 2024 May 1;15(5):e00697. doi: 10.14309/ctg.0000000000000697. Clin Transl Gastroenterol. 2024. PMID: 38488171 Free PMC article.
-
Current Medical Treatment for Alcohol-Associated Liver Disease.J Clin Exp Hepatol. 2022 Sep-Oct;12(5):1333-1348. doi: 10.1016/j.jceh.2022.02.001. Epub 2022 Feb 12. J Clin Exp Hepatol. 2022. PMID: 36157148 Free PMC article. Review.
-
Hepatic Encephalopathy and Nutrition Influences: A Narrative Review.Nutr Clin Pract. 2020 Feb;35(1):36-48. doi: 10.1002/ncp.10458. Epub 2019 Dec 23. Nutr Clin Pract. 2020. PMID: 31872484 Review.
Cited by
-
Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey.J Gastroenterol. 2025 Jul;60(7):866-876. doi: 10.1007/s00535-025-02232-0. Epub 2025 Mar 7. J Gastroenterol. 2025. PMID: 40053108 Free PMC article.
-
Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.J Clin Med. 2025 Feb 18;14(4):1358. doi: 10.3390/jcm14041358. J Clin Med. 2025. PMID: 40004887 Free PMC article.
-
Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions.World J Gastroenterol. 2025 Apr 21;31(15):103512. doi: 10.3748/wjg.v31.i15.103512. World J Gastroenterol. 2025. PMID: 40309228 Free PMC article. Review.
References
REFERENCES
-
- Georgiou A, Yannakoulia M, Papatheodoridis GV, Deutsch M, Alexopoulou A, Vlachogiannakos J, et al. Assessment of dietary habits and the adequacy of dietary intake of patients with cirrhosis‐the KIRRHOS study. Clin Nutr. 2021;40(6):3992–3998. https://doi.org/10.1016/j.clnu.2021.04.044
-
- Schuetz P, Fehr R, Baechli V, Geiser M, Deiss M, Gomes F, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet. 2019;393(10188):2312–2321. https://doi.org/10.1016/s0140‐6736(18)32776‐4
-
- DiMartini AF, Leggio L, Singal AK. Barriers to the management of alcohol use disorder and alcohol‐associated liver disease: strategies to implement integrated care models. Lancet Gastroenterol Hepatol. 2022;7(2):186–195. https://doi.org/10.1016/s2468‐1253(21)00191‐6
-
- Enomoto H, Ueno Y, Hiasa Y, Nishikawa H, Hige S, Takikawa Y, et al. Transition in the etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2020;55(3):353–362. https://doi.org/10.1007/s00535‐019‐01645‐y
-
- Lackner C, Spindelboeck W, Haybaeck J, Douschan P, Rainer F, Terracciano L, et al. Histological parameters and alcohol abstinence determine long‐term prognosis in patients with alcoholic liver disease. J Hepatol. 2017;66(3):610–618. https://doi.org/10.1016/j.jhep.2016.11.011
Grants and funding
LinkOut - more resources
Full Text Sources